Drug intelligence / Profile preview

calvatia lilacina extract

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral, Topical
01

Overview

Calvatia lilacina extract is a preparation derived from the fruiting body of the edible puffball mushroom Calvatia lilacina. Traditionally used in Chinese medicine for ailments involving bleeding and inflammation, modern research indicates the extract—particularly its protein fraction—demonstrates anti-cancer bioactivity including inhibition of proliferation and induction of apoptosis in several human cancer cell lines such as colorectal (SW480), breast, and monocytic leukemia cells. Mechanistically, the anticancer effects are mediated primarily through glutathione depletion, repression of γ-glutamylcysteine synthetase (γ-GCS), induction of mitochondrial dysfunction, and to some extent increased reactive oxygen species (ROS). Selectivity studies indicate less activity against normal cells. Purified extracts and fractions can differ in composition and potency, and the full safety and efficacy in humans has not been established[2][3][4][5].

Other names
calvatia lilacina protein extractcalvatia lilacina puffball extractLasiosphaera seu Calvatia
02

Targets

GCL (Gamma-glutamylcysteine Synthetase)

Beyond the preview

Go deeper on calvatia lilacina extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calvatia lilacina extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call